Host-mediated lung inflammation is present 1 , and drives mortality 2 , in the critical illness
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …

The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …

Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …

The Faculty of Intensive Care Medicine and Intensive Care Society Guideline Development
Group have used GRADE methodology to make the following recommendations for the …

Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype
that we have previously shown 1 to be highly efficient for discovery of genetic associations 2 . …

Background: Since publication of the 2012 Berlin definition of acute respiratory distress
syndrome (ARDS), several developments have supported the need for an expansion of the …

In patients requiring mechanical ventilation for acute lung injury or acute respiratory distress
syndrome (ARDS), tidal volume reduction decreases mortality, but the mechanisms of the …

Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic
variation influences the development of illness requiring critical care 1 or hospitalization 2 , 3 – …

Matrix metalloproteinases (MMPs) degrade all of the extracellular matrix components of the
intersititium and may play a role in abnormal alveolar permeability, which is a feature of …